![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 16, 10758-10764, April 16, 1999
From the Konar Center for Digestive and Liver Diseases, Department
of Medicine, University of Rochester School of Medicine and Dentistry,
Rochester, New York 14642
We have isolated, from canine pancreatic juice,
two 14-kDa proteins with secretin-releasing activity that had
N-terminal sequence homology with canine pancreatic phospholipase
A2 (PLA2). In this study we have obtained
evidence that secretin-releasing activity is an intrinsic property of
pancreatic PLA2. Porcine pancreatic PLA2 from
Sigma or Boehringer Mannheim was fractionated into several peaks by
reverse phase high performance liquid chromatography. They were tested
for stimulation of secretin release from murine neuroendocrine
intestinal tumor cell line STC-1 and secretin cells enriched mucosal
cell preparations isolated from rat upper small intestine. Each enzyme
preparation was found to contain several components of
secretin-releasing activity. Each bioactive fraction was purified to
homogeneity by rechromatography and then subjected to mass spectral
analysis and assays of PLA2 and secretin-releasing activities. It was found that the fraction with highest enzymatic activity also had the highest secretin-releasing activity and the same
Mr as porcine pancreatic PLA2.
Moreover, it also had the same N-terminal amino acid sequence (up to 30 residues determined) as that of porcine pancreatic PLA2,
suggesting that it was identical to the enzyme. Purified porcine
pancreatic PLA2 also stimulated secretin release
concentration-dependently from both STC-1 cells and a
mucosal cell preparation enriched in secretin-containing endocrine
cells isolated from rat duodenum. Abolishment of the enzymatic activity
by pretreatment with bromophenacyl bromide did not affect its
secretin-releasing activity. The stimulatory effect of purified
pancreatic PLA2 on secretin secretion from STC-1 cells was
inhibited by an L-type Ca2+ channel
blocker, by down-regulation of protein kinase C or by pretreatment of
the cell with pertussis toxin. It is concluded that porcine pancreatic
PLA2 possesses an intrinsic secretin-releasing activity
that was independent of its enzymatic activity. This action is
pertussis toxin-sensitive and is in part dependent on Ca2+ influx through the L-type channel and
activation of protein kinase C.
This article has been cited by other articles:
![]() |
K. Okamoto, J.-S. Kim, and B. K. Rubin Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L62 - L67. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zolese, M. Wozniak, P. Mariani, L. Saturni, E. Bertoli, and A. Ambrosini Different modulation of phospholipase A2 activity by saturated and monounsaturated N-acylethanolamines J. Lipid Res., April 1, 2003; 44(4): 742 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Huggins, A. C. Boileau, and D. Y. Hui Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E994 - E1001. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Li, T.-M. Chang, D. Wagner, and W. Y. Chey Pancreatic phospholipase A2 from the small intestine is a secretin-releasing factor in rats Am J Physiol Gastrointest Liver Physiol, August 1, 2001; 281(2): G526 - G532. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |